These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35641849)

  • 41. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
    Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
    BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute interstitial nephritis induced by proton-pump inhibitor: Uncommon indication of antireflux surgery.
    Ruiz-Clavijo García D; Zúñiga Ripa A; González de la Higuera Carnicer B; Valdivielso Cortazar E; Bolado Concejo F; Urman Fernández J; Vila Costas JJ
    Gastroenterol Hepatol; 2017 Feb; 40(2):87-88. PubMed ID: 26948177
    [No Abstract]   [Full Text] [Related]  

  • 43. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
    Hart E; Dunn TE; Feuerstein S; Jacobs DM
    Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pantoprazole-induced acute interstitial nephritis.
    Moore I; Sayer JA; Nayar A; Ahmed S; Tapson JS
    J Nephrol; 2004; 17(4):580-1. PubMed ID: 15372423
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proton pump inhibitors associated acute kidney injury and chronic kidney disease: data mining of US FDA adverse event reporting system.
    Wu B; Li D; Xu T; Luo M; He Z; Li Y
    Sci Rep; 2021 Feb; 11(1):3690. PubMed ID: 33574396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NSAIDs and kidney.
    Ejaz P; Bhojani K; Joshi VR
    J Assoc Physicians India; 2004 Aug; 52():632-40. PubMed ID: 15847359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse effects of proton pump inhibitors: fact or fake news?
    Schubert ML
    Curr Opin Gastroenterol; 2018 Nov; 34(6):451-457. PubMed ID: 30102612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Side effects of long-term use of proton pump inhibitors: practical considerations.
    Castellana C; Pecere S; Furnari M; Telese A; Matteo MV; Haidry R; Eusebi LH
    Pol Arch Intern Med; 2021 Jun; 131(6):541-549. PubMed ID: 33982542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute interstitial nephritis and PR3-ANCA following reintroduction of pembrolizumab: a case report.
    Mulroy M; Ghafouri S; Sisk A; Ribas A; Goshtaseb R; Cherry G; Shen J
    Immunotherapy; 2021 Mar; 13(4):283-288. PubMed ID: 33397120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute kidney injury following proton pump inhibitor therapy.
    Brewster UC; Perazella MA
    Kidney Int; 2007 Mar; 71(6):589-93. PubMed ID: 17164832
    [No Abstract]   [Full Text] [Related]  

  • 51. Acute tubulointerstitial nephritis in Scotland.
    Valluri A; Hetherington L; Mcquarrie E; Fleming S; Kipgen D; Geddes CC; Mackinnon B; Bell S
    QJM; 2015 Jul; 108(7):527-32. PubMed ID: 25434050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proton pump inhibitor-induced acute interstitial nephritis.
    Härmark L; van der Wiel HE; de Groot MC; van Grootheest AC
    Br J Clin Pharmacol; 2007 Dec; 64(6):819-23. PubMed ID: 17635502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Proton pump inhibitor-induced nephrotoxicity].
    Klatte DCF; Wiegersma JS; Dekker FW; Gansevoort RT
    Ned Tijdschr Geneeskd; 2021 Sep; 165():. PubMed ID: 34523835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Proton pump inhibitor - side effects and complications of long-term proton pump inhibitor administration].
    Ueberschaer H; Allescher HD
    Z Gastroenterol; 2017 Jan; 55(1):63-74. PubMed ID: 28073136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Emergent adverse effects of proton pump inhibitors].
    Bourne C; Charpiat B; Charhon N; Bertin C; Gouraud A; Mouchoux C; Skalli S; Janoly-Dumenil A
    Presse Med; 2013 Feb; 42(2):e53-62. PubMed ID: 23237784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis.
    Tergast TL; Wranke A; Laser H; Gerbel S; Manns MP; Cornberg M; Maasoumy B
    Liver Int; 2018 Sep; 38(9):1602-1613. PubMed ID: 29675988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of bias in non-randomized observational studies assessing the relationship between proton-pump inhibitors and adverse kidney outcomes: a systematic review.
    Rajan P; Iglay K; Rhodes T; Girman CJ; Bennett D; Kalantar-Zadeh K
    Therap Adv Gastroenterol; 2022; 15():17562848221074183. PubMed ID: 35173802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concomitant Proton Pump Inhibitors and Immune Checkpoint Inhibitors Increase Nephritis Frequency.
    Kato K; Mizuno T; Koseki T; Ito Y; Hatano M; Takahashi K; Yamada S; Tsuboi N
    In Vivo; 2021; 35(5):2831-2840. PubMed ID: 34410975
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proton pump inhibitors and acute interstitial nephritis.
    Ray S; Delaney M; Muller AF
    BMJ; 2010 Sep; 341():c4412. PubMed ID: 20861097
    [No Abstract]   [Full Text] [Related]  

  • 60. Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients.
    Shirali AC; Perazella MA; Gettinger S
    Am J Kidney Dis; 2016 Aug; 68(2):287-291. PubMed ID: 27113507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.